Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2 clinical trial assessing Trichomylin softgel capsules

Next Previous
Search
Trial Profile

Phase 2 clinical trial assessing Trichomylin softgel capsules

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cannabinoid therapeutic-ZYUS Life Sciences (Primary)
  • Indications Cancer pain
  • Focus Proof of concept; Therapeutic Use

    • Most Recent Events

    • 30 Jul 2024 According to ZYUS Life Sciences media release, company has received a No Objection Letter from Health Canada for a proof-of-concept trial respecting of Trichomylin softgel capsules.
    • 04 Jun 2024 According to ZYUS Life Sciences media release, the company has received a Cannabis Drug License issued pursuant to the Cannabis Act (Canada) and Cannabis Regulations which pertains specifically to its processing facility located in Saskatoon, Saskatchewan. This license provides a robust framework for the manufacture of Trichomylin softgel capsules for this Phase 2 Clinical Trial.
    • 01 Feb 2024 According to ZYUS Life Sciences media release, following an announcement on December 5, 2023, company is moving forward with the decision to fast-track and progress directly to a full Phase 2 Clinical Trial in Canada.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top